Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin extended release with or without ezetimibe versus ezetimibe alone in dyslipidemic patients with prior statin-associated muscle complaints
2004-004208-19Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dyslipidemia comparing Lescol XL + ezetimibe, Lescol XL monotherapy and ezetimibe monotherapy (3 arms). Started Mar 2005; status: completed.
02
Drugs
fluvastatinezetimibe
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on 2004-004208-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004208-19.